Judith A. Shizuru

Best Publications

• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

  Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  1660
  Citations

• Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

  Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf

  688
  Citations

• The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.

  Irving L. Weissman;Judith A. Shizuru

  615
  Citations

• Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

  John D. Scandling;Stephan Busque;Sussan Dejbakhsh-Jones;Claudia Benike

  604
  Citations

• CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

  Jay Y. Spiegel;Shabnum Patel;Lori Muffly;Nasheed M. Hossain

  531
  Citations

• Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.

  Alexander Filatenkov;Jeanette Baker;Antonia M.S. Mueller;Justin Kenkel

  502
  Citations

• Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ

  N Sarvetnick;J Shizuru;D Liggitt;D Liggitt;L Martin

  497
  Citations

• Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes

  JA Shizuru;C Taylor-Edwards;BA Banks;AK Gregory

  496
  Citations

• Protective conditioning for acute graft-versus-host disease.

  Robert Lowsky;Tsuyoshi Takahashi;Yin Ping Liu;Sussan Dejbakhsh-Jones

  440
  Citations

• Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

  Heather G. Shilling;Karina L. McQueen;Nathalie W. Cheng;Judith A. Shizuru

  375
  Citations

• Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.

  Jonathan T. Sockolosky;Eleonora Trotta;Giulia Parisi;Lora Picton

  364
  Citations

• Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

  Mohamed L. Sorror;Barry E. Storer;Brenda M. Sandmaier;Michael Maris

  352
  Citations

• Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors

  Ute Hegenbart;Dietger Niederwieser;Brenda M. Sandmaier;Michael B. Maris

  331
  Citations

• Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.

  Maria T Millan;Judith A Shizuru;Petra Hoffmann;Sussan Dejbakhsh-Jones

  303
  Citations

• Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production

  Jeanette Baker;Michael R. Verneris;Maki Ito;Judith A. Shizuru

  295
  Citations

• Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

  Steven M. Horwitz;Robert S. Negrin;Karl G. Blume;Sheila Breslin

  260
  Citations

• Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

  Boglarka Gyurkocza;Rainer Storb;Barry E. Storer;Thomas R. Chauncey

  252
  Citations

• Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation

  J. D. Scandling;S. Busque;J. A. Shizuru;R. Lowsky

  245
  Citations

• Islet allograft survival after a single course of treatment of recipient with antibody to L3T4.

  JA Shizuru;AK Gregory;CT Chao;CG Fathman

  240
  Citations

• TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.

  Holbrook E. Kohrt;Brit B. Turnbull;Kartoosh Heydari;Judith A. Shizuru

  237
  Citations